Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate

Calcified Tissue International

Volumn 76, Issue 6, 2005, Pages 448-457

  Funayama, H ^a   Ohsako, M ^b   Monma, Y ^a   Mayanagi, H ^a   Sugawara, S ^a   Endo, Y ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOYO UNIVERSITY   (Japan)

Author keywords

Alendronate; Bisphosphonates; Clodronate; Etidronate; Side effects

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; HISTIDINE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME INDUCTION; INFLAMMATION; MALE; MOUSE; NONHUMAN; OSTEOLYSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SAFETY;

ALENDRONATE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIMETABOLITES; BONE AND BONES; BONE RESORPTION; CLODRONIC ACID; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; HISTIDINE DECARBOXYLASE; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C;

EID: 23944443825     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0180-3     Document Type: Article

References (30)

1. GA Rodan HA Fleisch 1996. J Clin Invest 97 2692 2696
2. Bonjour, JP, Rizzoli, R, Ammann, P, Chevalley, T (1994) "Bisphosphonates in clinical medicine" In: Heershe, NM, Kanis, JK (eds.), Bone and mineral research, vol. 8, Elsevier Science BV, Amsterdam, pp 205-264
3. Geddes, AD, D'Souza, SM, Ebentino, FH, Kenneth, JI (1994) "Bisphosphonates: structure-activity relationships and therapeutic implications" In: Heershe, NM, Kanis, JK (eds.), Bone and mineral research, vol. 8, elsevier Science BV, Amsterdam, pp 265-306
4. S Adami AK Bhalla R Dorizzi F Montesani S Rosini G Salvagno V Lo Cascio 1987 The acute phase response after bisphosphonate administration Calcif Tissue Int 41 326 331
5. A Sauty M Pecherstorfer I Zimmer-Roth P Fioroni L Juillerat M Markert H Ludwig P Leuenberger P Burckhardt D Thiébaud 1996 Interleukin-6 and tumor necrosis factor α levels after bisphosphonates treatment in vitro and in patients with malignancy Bone 18 133 139
6. D Thiébaud A Sauty P Burckhardt P Leuenberger L Sitzler JR Green A Kandra J Zieschange P De Ibarra Palacios 1997 An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates Calcif Tissue Int 61 386 392
7. E Siris 1993 Bisphosphonates and iritis Lancet 341 436 437
8. V Macarol FT Frauenfelder 1994 Pamidronate disodium and possible ocular adverse drug reactions Am J Ophthamol 118 220 224
9. HA Fleisch 1997 Bisphosphonates: preclinical aspects and use in osteoporosis Anal Med 29 56 62
10. MA Blank BL Ems GW Gibson WR Myers SK Berman RJ Phipps PN Smith 1997 Nonclinical model for assessing gastric effects of bisphosphonates Dig Dis Sci 42 281 288
11. Y Endo N Nakamura T Kikuchi H Shinoda K Takeda Y Nitta K Kumagai 1993 Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo Calcif Tissue Int 152 248 254
12. M Nakamura T Ando A Masataka K Kumagai Y Endo 1996 Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice Br J Pharmacol 119 205 212
13. S Sugawara M Shibazaki H Takada K Kosugi Y Endo 1998 Contrasting effects of an aminobisphosphonate, a potent inhibitor of bone resorption, on lipopolysaccharide-induced production of interleukin-1 and tumour necrosis factor α in mice Br J Pharmacol 125 735 740
14. H Funayama H Mayanagi H Takada Y Endo 2000 Elevation of histidine decarboxylase activity in the mandible of mice by Prevotella intermedia lipopolysaccharide and its augmentation by an aminobisphosphonate Arch Oral Biol 45 787 795
15. K Yamaguchi K Motegi Y Iwakura Y Endo 2000 Involvement of interleukin-1 in the inflammatory actions of aminobisphosphonates in mice Br J Pharmacol 130 1646 1654
16. Y Endo M Shibazaki M Nakamura H Kosugi 1999 Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate BrJ Pharmacol 126 903 910
17. Y Monma H Funayama H Mayanagi Y Endo 2004 Effects of weekly administration of alendronate + clodronate on young mouse tibia: localized action at the proximal growth plate Calcif Tissue Int 74 115 121
18. M Sato W Grasser N Endo R Akins H Simmons DD Thompson E Golub GA Rodan 1991 Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure J Clin Invest 88 2095 2105
19. A Jung S Bisaz H Fleisch 1973 The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals Calcif Tissue Res 11 269 280
20. JC Frith MD Rogers 2003 Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro J Bone Miner Res 18 204 212
21. J Mönnköknen H-M Koponen P Ylitalo 1989 Comparison of the distribution of three bisphosphonates in mice Pharmacol Toxicol 65 294 298
22. A Töyräs J Ollikainen M Taskinen J Mönkkönen 2003 Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro Eur J Pharmaceutical Sci 19 223 230
23. V Kunzmann E Bauer M Wilhelm 1999 γδ T-cell stimulation by pamidronate New Engl J Med 340 737 738
24. V Kunzmann E Bauer J Feurle F Weiβinger H-P Tony M Wilhelm 2000 Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma Blood 96 384 392
25. F Miyagawa Y Tanaka S Yamashita N Minato 2001 Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human γδ T cells by aminobisphosphonate antigen J Immunol 166 5508 5514
26. 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats Calcif Tissue Res 11 196 214
27. SC Miller WSS Jee 1977 The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethan-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia Calcif Tissue Res 23 207 214
28. HIJ Harinck SE Papapoulos HJ Blanksma AJ Moolenaar P Vermeij OLM Bijvoet 1987 Paget's disease of bone: early and late responses to three modes of treatment with aminohydroxypropylidene bisphosphonate (APD) Br Med J 295 1301 1305
29. DH Schweitzer MOVD Ruit GVD Pruijm CWGM Löwik SE Papapoulos 1995 Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate J Bone Mineral Res 10 956 962
30. PJ Richards N Amos AS Williams BD Williams 1999 Pro-inflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo Rheumatology 38 984 991